These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35984010)

  • 81. Cancer gland rupture as a potential risk factor for lymph node metastasis in early colorectal adenocarcinoma with deep submucosal invasion.
    Oishi K; Ito T; Sakonishi D; Uchida K; Sekine M; Negi M; Kobayashi D; Miura K; Akashi T; Eishi Y
    Histopathology; 2020 Mar; 76(4):603-612. PubMed ID: 31643099
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Intratumoral budding: A novel prognostic biomarker for tumor recurrence and a potential predictor of nodal metastasis in uterine cervical cancer.
    Chong GO; Jee-Young Park N; Han HS; Cho J; Kim MG; Choi Y; Yeo JY; Lee YH; Hong DG; Park JY
    Eur J Surg Oncol; 2021 Dec; 47(12):3182-3187. PubMed ID: 34284905
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer.
    Nanthamongkolkul K; Hanprasertpong J
    Oncol Res Treat; 2018; 41(4):194-198. PubMed ID: 29562222
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer.
    Sun Y; Wang Y; Cheng X; Wu W; Liu Q; Chen X; Ren F
    Eur J Surg Oncol; 2024 Apr; 50(4):108260. PubMed ID: 38484492
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.
    Chen L; Tang K; Wang S; Chen D; Ding K
    Cancer Control; 2021; 28():10732748211026668. PubMed ID: 34155922
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Sex-specific differences in risk factors of lymph node metastasis in patients with early gastric cancer.
    Ryu ES; Chang SJ; An J; Yang JY; Chung JW; Kim YJ; Kim KO; Park DK; Kwon KA; Nam S; Lee WK; Kim JH
    PLoS One; 2019; 14(10):e0224019. PubMed ID: 31626653
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A clinical model for predicting lymph node metastasis in submucosal invasive (T1) colorectal cancer.
    Macias-Garcia F; Celeiro-Muñoz C; Lesquereux-Martinez L; Gude-Sampedro F; Uribarri-Gonzalez L; Abdulkader I; Alvarez-Castro A; Dominguez-Muñoz JE
    Int J Colorectal Dis; 2015 Jun; 30(6):761-8. PubMed ID: 25700808
    [TBL] [Abstract][Full Text] [Related]  

  • 88. TYMS serves as a prognostic indicator to predict the lymph node metastasis in Chinese patients with colorectal cancer.
    Lu Y; Zhuo C; Cui B; Liu Z; Zhou P; Lu Y; Wang B
    Clin Biochem; 2013 Oct; 46(15):1478-83. PubMed ID: 23810585
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinicopathological features and risk factors for lymph node metastasis in early-stage non-ampullary duodenal adenocarcinoma.
    Yoshimizu S; Kawachi H; Yamamoto Y; Nakano K; Horiuchi Y; Ishiyama A; Tsuchida T; Yoshio T; Hirasawa T; Ito H; Fujisaki J
    J Gastroenterol; 2020 Aug; 55(8):754-762. PubMed ID: 32533301
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer.
    Beaton C; Twine CP; Williams GL; Radcliffe AG
    Colorectal Dis; 2013 Jul; 15(7):788-97. PubMed ID: 23331927
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer.
    Kim JK; Rhee YY; Bae JM; Kim JH; Koh SJ; Lee HJ; Im JP; Kim MJ; Ryoo SB; Jeong SY; Park KJ; Park JW; Kang GH
    BMC Cancer; 2022 Aug; 22(1):861. PubMed ID: 35933369
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: A retrospective cohort study.
    Al-Sukhni E; Attwood K; Gabriel EM; LeVea CM; Kanehira K; Nurkin SJ
    Int J Surg; 2017 Jan; 37():42-49. PubMed ID: 27600906
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions.
    Yasue C; Chino A; Takamatsu M; Namikawa K; Ide D; Saito S; Igarashi M; Fujisaki J
    J Gastroenterol; 2019 Aug; 54(8):708-717. PubMed ID: 30810812
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study.
    Kawachi H; Eishi Y; Ueno H; Nemoto T; Fujimori T; Iwashita A; Ajioka Y; Ochiai A; Ishiguro S; Shimoda T; Mochizuki H; Kato Y; Watanabe H; Koike M; Sugihara K
    Mod Pathol; 2015 Jun; 28(6):872-9. PubMed ID: 25720321
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: a systematic review and meta-analysis.
    Mou S; Soetikno R; Shimoda T; Rouse R; Kaltenbach T
    Surg Endosc; 2013 Aug; 27(8):2692-703. PubMed ID: 23392988
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
    Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
    Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Treatment Decision for Locally Resected T1 Colorectal Carcinoma-Verification of the Japanese Guideline Criteria for Additional Surgery Based on Long-Term Clinical Outcomes.
    Oka S; Tanaka S; Kajiwara Y; Saito S; Fukunaga Y; Takamatsu M; Kawachi H; Hotta K; Ikematsu H; Kojima M; Saito Y; Yamada M; Kanemitsu Y; Sekine S; Nagata S; Yamada K; Kobayashi N; Ishihara S; Saitoh Y; Matsuda K; Togashi K; Komori K; Ishiguro M; Kuwai T; Okuyama T; Ohuchi A; Ohnuma S; Sakamoto K; Sugai T; Katsumata K; Matsushita HO; Yamano HO; Eda H; Uraoka T; Akimoto N; Kobayashi H; Sugihara K; Ueno H
    Am J Gastroenterol; 2024 Oct; 119(10):2019-2027. PubMed ID: 38345215
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Predictors of Lymph Node Metastasis and Prognosis in pT1 Colorectal Cancer Patients with Signet-Ring Cell and Mucinous Adenocarcinomas.
    Song BR; Xiao CC; Wu ZK
    Cell Physiol Biochem; 2017; 41(5):1753-1765. PubMed ID: 28365687
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Novel applications of histopathological markers to distinguish prognostic subgroups in colorectal adenocarcinoma.
    Yuan Y; Ren W; Zhu J; Ji S; Yang Q
    Ann Med; 2023; 55(2):2244181. PubMed ID: 37557892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.